Progressive epithelial to mesenchymal transitions in ARCaPE prostate cancer cells during xenograft tumor formation and metastasis

Prostate

Volumn 70, Issue 5, 2010, Pages 518-528

  He, Hui ^a,b   Yang, Xiaojian ^b   Davidson, Alec J ^c   Wu, Daqing ^b   Marshall, Fray F ^b   Chung, Leland W K ^b   Zhau, Haiyen E ^b   Wang, Ruoxiang ^b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

Epithelial to mesenchymal transition; Orthotopic tumor formation; Prostate cancer progression and metastasis; Red fluorescence protein

Indexed keywords

RED FLUORESCENT PROTEIN; VIMENTIN;

ARTICLE; ASCITES; BLOOD; BONE MARROW; CANCER CELL; CARCINOGENESIS; CELL ISOLATION; CELL PROLIFERATION; CELL SHAPE; CELL SIZE; CELL STRUCTURE; CELL TRANSFORMATION; CONTROLLED STUDY; EPITHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INCIDENCE; LUNG; MESENCHYME CELL; METASTASIS; MICROENVIRONMENT; MOLECULAR CLONING; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; TUMOR GROWTH; XENOGRAFT; ANIMAL; CANCER TRANSPLANTATION; EPITHELIUM; MALE; MESODERM; MOUSE; PATHOLOGY; PROSTATE TUMOR; STROMA CELL;

ANIMALS; EPITHELIUM; HUMANS; MALE; MESODERM; MICE; NEOPLASM TRANSPLANTATION; PHENOTYPE; PROSTATIC NEOPLASMS; STROMAL CELLS; TRANSPLANTATION, HETEROLOGOUS;

EID: 77949877839     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21086     Document Type: Article

References (36)

1. Poste G, Greig R. On the genesis and regulation of cellular heterogeneity in malignant tumors. Invasion Metastasis 1982;2(3):137-176.
2. Rubin H. The significance of biological heterogeneity. Cancer Metastasis Rev 1990;9 (1):1-20.
3. Smith HS, Wolman SR, Hackett AJ. The biology of breast cancer at the cellular level. Biochim Biophys Acta 1984;738 (3):103-123.
4. Christiansen JJ, Rajasekaran AK. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 2006;66 (17):8319-8326. (Pubitemid 44449137)
5. De Marzo AM, Knudsen B, Chan-Tack K, Epstein JI. E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens. Urology 1999;53 (4):707-713. (Pubitemid 29163034)
6. Giroldi LA, Schalken JA. Decreased expression of the intercellular adhesion molecule E-cadherin in prostate cancer: Biological significance and clinical implications. Cancer Metastasis Rev 1993;12 (1):29-37.
7. Morton RA, Ewing CM, Nagafuchi A, Tsukita S, Isaacs WB. Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells. Cancer Res 1993;53 (15):3585-3590. (Pubitemid 23229641)
8. Otto T, Rembrink K, Goepel M, Meyer-Schwickerath M, Rubben H. E-cadherin: A marker for differentiation and invasiveness in prostatic carcinoma. Urol Res 1993;21 (5):359-362.
9. Rembrink K, Otto T, Goepel M, Enzawi SM, Rubben H. Ecadherin: Expression of the epithelial cell-cell-adhesion molecule in prostatic carcinoma and normal prostate. Investig Urol (Berl) 1994;5:24-27.
10. Umbas R, Isaacs WB, Bringuier PP, Schaafsma HE, Karthaus HF, Oosterhof GO, Debruyne FM, Schalken JA. Decreased Ecadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 1994;54 (14):3929-3933. (Pubitemid 24241218)
11. Umbas R, Schalken JA, Aalders TW, Carter BS, Karthaus HF, Schaafsma HE, Debruyne FM, Isaacs WB. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 1992;52 (18):5104-5109.
12. Wernert N, Seitz G, Achtstatter T. Immunohistochemical investigation of different cytokeratins and vimentin in the prostate from the fetal period up to adulthood and in prostate carcinoma. Pathol Res Pract 1987;182 (5):617-626.
13. Zhau HE, Pisters LL, Hall MC, Zhao LS, Troncoso P, Pollack A, Chung LW. Biomarkers associated with prostate cancer progression. J Cell Biochem Suppl 1994;19:208-216. (Pubitemid 24306470)
14. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED, Thompson EW. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 2007;213 (2):374-383. (Pubitemid 47509716)
15. Xu J, Wang R, Xie ZH, Odero-Marah V, Pathak S, Multani A, Chung LW, Zhau HE. Prostate cancer metastasis: Role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis. Prostate 2006;66 (15):1664-1673. (Pubitemid 44646357)
16. Zhau HE, Odero-Marah V, Lue HW, Nomura T, Wang R, Chu G, Liu ZR, Zhou BP, Huang WC, Chung LW. Epithelial to mesenchymal transition (EMT) in human prostate cancer: Lessons learned from ARCaP model. Clin Exp Metastasis 2008;25 (6):601-610.
17. Zhau HE, Chang SM, Chen BQ, Wang Y, Zhang H, Kao C, Sang QA, Pathak SJ, Chung LW. Androgen-repressed phenotype in human prostate cancer. Proc Natl Acad Sci USA 1996;93 (26):15152-15157. (Pubitemid 27009568)
18. Nolan C, editor. Molecular cloning:A laboratory manual, Vol.3, 2nd edition. Cold Spring Harbor: Laboratory Press; 1989. p. 18.32.
19. Odero-Marah VA, Wang R, Chu G, Zayzafoon M, Xu J, Shi C, Marshall FF, Zhau HE, Chung LW. Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells. Cell Res 2008;18 (8):858-870.
20. Grunert S, Jechlinger M, Beug H. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell Biol 2003;4 (8):657-665. (Pubitemid 36934968)
21. Pathak S, Nemeth MA, Multani AS, Thalmann GN, von Eschenbach AC, Chung LW. Can cancer cells transform normal host cells into malignant cells? Br J Cancer 1997;76 (9):1134-1138.
22. Mackenzie NC, Raz E. Found in translation: A new player in EMT. Dev Cell 2006;11 (4):434-436. (Pubitemid 44430906)
23. Caligaris-Cappio F, Gregoretti MG, Merico F, Gottardi D, Ghia P, Parvis G, Bergui L. Bone marrow microenvironment and the progression of multiple myeloma. Leuk Lymphoma 1992;8 (1-2):15-22. (Pubitemid 24287825)
24. Chung LW, Baseman A, Assikis V, Zhau HE. Molecular insights into prostate cancer progression: The missing link of tumor microenvironment. J Urol 2005;173 (1):10-20. (Pubitemid 39627663)
25. Elenbaas B, Weinberg RA. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res 2001;264 (1):169-184. (Pubitemid 32989090)
26. Heppner GH, Miller FR. The cellular basis of tumor progression. Int Rev Cytol 1998;177:1-56.
27. Nicolson GL. Generation of phenotypic diversity and progression in metastatic tumor cells. Cancer Metastasis Rev 1984;3 (1):25-42.
28. Price JE. Host-tumor interactions in the progression of breast cancer metastasis. In Vivo 1994;8 (1):145-154. (Pubitemid 24156545)
29. Sung SY, Chung LW. Prostate tumor-stroma interaction: Molecular mechanisms and opportunities for therapeutic targeting. Differentiation 2002;70 (9-10):506-521. (Pubitemid 36194316)
30. Tlsty TD. Stromal cells can contribute oncogenic signals. Semin Cancer Biol 2001;11 (2):97-104.
31. Yuan J, Glazer PM. Mutagenesis induced by the tumor microenvironment. Mutat Res 1998;400 (1-2):439-446.
32. Graham TR, Zhau HE, Odero-Marah VA, Osunkoya AO, Kimbro KS, Tighiouart M, Liu T, Simons JW, O'Regan RM. Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Res 2008;68 (7):2479-2488.
33. Wu D, Zhau HE, Huang WC, Iqbal S, Habib FK, Sartor O, Cvitanovic L, Marshall FF, Xu Z, Chung LW. cAMP-responsive element-binding protein regulates vascular endothelial growth factor expression: Implication in human prostate cancer bone metastasis. Oncogene 2007;26 (35):5070-5077. (Pubitemid 47206947)
34. Chung LW, Huang WC, Sung SY, Wu D, Odero-Marah V, Nomura T, Shigemura K, Miyagi T, Seo S, Shi C, Molitierno J, Elmore J, Anderson C, Isotani S, Edlund M, Hsieh CL, Wang R, Shehata B, Zhau HE. Stromal-epithelial interaction in prostate cancer progression. Clin Genitourin Cancer 2006;5 (2):162-170.
35. Rhee HW, Zhau HE, Pathak S, Multani AS, Pennanen S, Visakorpi T, Chung LW. Permanent phenotypic and genotypic changes of prostate cancer cells cultured in a three-dimensional rotating-wall vessel. In Vitro Cell Dev Biol Anim 2001;37 (3):127-140.
36. Sung SY, Hsieh CL, Law A, Zhau HE, Pathak S, Multani AS, Lim S, Coleman IM, Wu LC, Figg WD, Dahut WL, Nelson P, Lee JK, Amin MB, Lyles R, Johnstone PA, Marshall FF, Chung LW. Coevolution of prostate cancer and bone stroma in three-dimensional coculture: Implications for cancer growth and metastasis. Cancer Res 2008;68 (23):9996-10003.